Design, synthesis and glycosidase inhibition studies of novel triazole fused iminocyclitol-δ-lactams.
Catalytic Domain
Computer Simulation
Cyclitols
/ chemistry
Cycloaddition Reaction
Decarboxylation
Drug Design
Escherichia coli
/ enzymology
Glycoside Hydrolase Inhibitors
/ chemistry
Hydrogen Bonding
Imines
/ chemistry
Lactams
/ chemistry
Molecular Docking Simulation
Monte Carlo Method
Saccharomyces cerevisiae
/ enzymology
Triazoles
/ chemistry
alpha-Glucosidases
/ drug effects
Journal
Organic & biomolecular chemistry
ISSN: 1477-0539
Titre abrégé: Org Biomol Chem
Pays: England
ID NLM: 101154995
Informations de publication
Date de publication:
31 01 2019
31 01 2019
Historique:
pubmed:
12
1
2019
medline:
4
4
2019
entrez:
12
1
2019
Statut:
ppublish
Résumé
Synthesis of novel triazole fused iminocyclitol-δ-lactams is described. The synthetic sequence involves the intermolecular [3 + 2] cycloaddition reaction of five-membered iminocyclitol derived azides with diethylacetylene dicarboxylate followed by intramolecular lactamisation, decarboxylation/reduction and final deprotection. Compound 3 is found to be a selective inhibitor of α-glucosidase from baker's yeast while two other compounds (2 and 4) that possess an additional hydroxymethyl group in the triazole ring are selective against β-galactosidase from E. coli. Docking studies suggest the significance of the lactam carbonyl group for effective binding of these inhibitors with the active sites through hydrogen bonding.
Substances chimiques
Cyclitols
0
Glycoside Hydrolase Inhibitors
0
Imines
0
Lactams
0
Triazoles
0
alpha-Glucosidases
EC 3.2.1.20
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM